Swiss National Bank Acquires 3,600 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Swiss National Bank boosted its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 1.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 336,702 shares of the health services provider’s stock after buying an additional 3,600 shares during the period. Swiss National Bank owned approximately 0.20% of Teladoc Health worth $3,061,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Point72 Asset Management L.P. increased its position in Teladoc Health by 57.8% during the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after acquiring an additional 3,063,172 shares during the period. Geode Capital Management LLC grew its position in Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock worth $36,042,000 after purchasing an additional 56,864 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock valued at $22,213,000 after buying an additional 384,528 shares during the last quarter. Invenomic Capital Management LP lifted its stake in shares of Teladoc Health by 155.2% in the third quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock valued at $13,534,000 after buying an additional 896,552 shares during the period. Finally, Maple Rock Capital Partners Inc. acquired a new stake in Teladoc Health during the third quarter worth about $11,291,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have commented on TDOC. Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Royal Bank of Canada upped their target price on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Bank of America increased their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Finally, The Goldman Sachs Group reduced their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a report on Monday, March 3rd. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.26.

Insider Transactions at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.95% of the stock is owned by company insiders.

Teladoc Health Trading Up 0.1 %

TDOC stock opened at $8.65 on Thursday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of -1.50 and a beta of 1.27. The business has a fifty day moving average price of $10.38 and a 200 day moving average price of $9.77. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.43.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.